Tactile Systems Technology Inc (NASDAQ:TCMD) COO Robert J. Folkes sold 2,500 shares of the stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $70.36, for a total value of $175,900.00. Following the completion of the transaction, the chief operating officer now directly owns 111,654 shares of the company’s stock, valued at approximately $7,855,975.44. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Shares of NASDAQ:TCMD traded up $0.43 during trading on Thursday, hitting $62.93. The stock had a trading volume of 301,218 shares, compared to its average volume of 271,254. Tactile Systems Technology Inc has a 12 month low of $30.21 and a 12 month high of $76.63. The firm has a market capitalization of $1.24 billion, a P/E ratio of 224.75, a P/E/G ratio of 10.02 and a beta of 2.36.

Several large investors have recently made changes to their positions in TCMD. Geode Capital Management LLC increased its position in Tactile Systems Technology by 11.6% during the 4th quarter. Geode Capital Management LLC now owns 195,598 shares of the company’s stock valued at $8,908,000 after buying an additional 20,284 shares in the last quarter. HRT Financial LLC bought a new position in Tactile Systems Technology during the 4th quarter valued at approximately $304,000. Macquarie Group Ltd. increased its position in Tactile Systems Technology by 2.9% during the 4th quarter. Macquarie Group Ltd. now owns 47,676 shares of the company’s stock valued at $2,172,000 after buying an additional 1,337 shares in the last quarter. Legal & General Group Plc increased its position in Tactile Systems Technology by 1.0% during the 4th quarter. Legal & General Group Plc now owns 36,235 shares of the company’s stock valued at $1,629,000 after buying an additional 356 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its position in Tactile Systems Technology by 0.4% during the 4th quarter. Thrivent Financial for Lutherans now owns 351,083 shares of the company’s stock valued at $15,992,000 after buying an additional 1,472 shares in the last quarter. 98.90% of the stock is owned by hedge funds and other institutional investors.

Several research analysts have recently issued reports on TCMD shares. BidaskClub lowered Tactile Systems Technology from a “buy” rating to a “hold” rating in a research report on Wednesday, November 21st. ValuEngine lowered Tactile Systems Technology from a “buy” rating to a “hold” rating in a research report on Friday, December 7th. Northland Securities raised Tactile Systems Technology from an “under perform” rating to a “market perform” rating in a research report on Wednesday, January 2nd. Piper Jaffray Companies increased their target price on Tactile Systems Technology to $80.00 and gave the stock a “positive” rating in a research report on Monday, January 7th. Finally, Zacks Investment Research lowered Tactile Systems Technology from a “buy” rating to a “hold” rating in a research report on Thursday, January 10th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $70.00.

WARNING: “Insider Selling: Tactile Systems Technology Inc (TCMD) COO Sells 2,500 Shares of Stock” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.watchlistnews.com/insider-selling-tactile-systems-technology-inc-tcmd-coo-sells-2500-shares-of-stock/2890492.html.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers proprietary Flexitouch system, an at-home solution for lymphedema patients; and ACTitouch system, a home-based solution for chronic venous insufficiency patients.

Recommended Story: Derivative

Insider Buying and Selling by Quarter for Tactile Systems Technology (NASDAQ:TCMD)

Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.